Arch Therapeutics Negotiating a Collaboration Agreement With CURAM Centre for Research in Medical Devices - Seite 3

About CÚRAM

CÚRAM is engaged in research to radically improve health outcomes for patients by developing innovative implantable 'smart' medical devices to treat major unmet medical needs. This research will position Ireland as the leader in developing medical device technologies, which will provide affordable transformative solutions for chronic diseases.

Notice Regarding Forward-Looking Statements

This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, our plans to enter into a collaboration agreement with CÚRAM, references to novel technologies and methods, our business and product development plans and projections, or market information. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Factors that may affect both the timing of and the Company's ability to execute a collaboration agreement with CÚRAM include, but are not limited to, the success or failure of negotiations, Board approvals, trade, legal, social, political and economic risks, and the Company's ability to raise additional capital to perform its expected obligations under the collaboration agreement. Other factors that could also cause actual results to differ from those projected in any forward-looking statements include, but are not limited to, the inherent uncertainties associated with developing new products or technologies and operating as a development stage company, our ability to retain important members of our management team and attract other qualified personnel, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, our ability to develop and commercialize products based on our technology platform, and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov.